Madison-based biotechnology company Promega Corporation is drawing praise for its work in helping rapidly develop and launch a new test for the COVID-19 disease—with an assist from the Center for Quick Response Manufacturing (QRM) at UW-Madison.
The QRM Center, which is based in the Department of Industrial and Systems Engineering and is a partnership between industry, faculty and students, assists member companies in developing and implementing lead-time reduction principles.
Promega, a QRM Center member, played a crucial role in the development of diagnostic testing technology company Co-Diagnostics’ new Logix Smart COVID-19 Test. The test is approved and available in Europe as an in vitro diagnostic and continues to advance toward emergency use clearance as an in vitro diagnostic in the United States and India.
Co-Diagnostics used the Promega PCR Optimization Kit to refine its custom master mix for coronavirus testing. The Promega custom operations team then manufactured, quality control tested, dispensed and packed the customized polymerase chain reaction assay reagents under the highest quality standards in less than 10 business days.
To read more about Promega’s use of QRM principles, visit the center’s website.